BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11479827)

  • 1. [Naltrexone in the treatment of dissociative disorders--reflections with regard to a comprehensive therapeutic concept of borderline disorders].
    Bolm T; Piegler T
    Psychiatr Prax; 2001 Jul; 28(5):214-8. PubMed ID: 11479827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of dissociative symptoms in borderline personality disorder with naltrexone: supplementary comments].
    Schmahl C; Bohus M
    Nervenarzt; 2000 May; 71(5):427. PubMed ID: 10846724
    [No Abstract]   [Full Text] [Related]  

  • 3. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial.
    Bohus MJ; Landwehrmeyer GB; Stiglmayr CE; Limberger MF; Böhme R; Schmahl CG
    J Clin Psychiatry; 1999 Sep; 60(9):598-603. PubMed ID: 10520978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naltrexone as a treatment for repetitive self-injurious behaviour:an open-label trial.
    Roth AS; Ostroff RB; Hoffman RE
    J Clin Psychiatry; 1996 Jun; 57(6):233-7. PubMed ID: 8666558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone treatment of self-injurious behavior.
    Godart NT; Agman G; Perdereau F; Jeammet P
    J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1076-8. PubMed ID: 10986803
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of naltrexone for dissociative symptoms in borderline personality disorder.
    Schmahl C; Kleindienst N; Limberger M; Ludäscher P; Mauchnik J; Deibler P; Brünen S; Hiemke C; Lieb K; Herpertz S; Reicherzer M; Berger M; Bohus M
    Int Clin Psychopharmacol; 2012 Jan; 27(1):61-8. PubMed ID: 22002175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment of post-traumatic stress disorder with naltrexone: an open-label preliminary study.
    Lubin G; Weizman A; Shmushkevitz M; Valevski A
    Hum Psychopharmacol; 2002 Jun; 17(4):181-5. PubMed ID: 12404685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dissociative experiences of borderline patients.
    Zanarini MC; Ruser T; Frankenburg FR; Hennen J
    Compr Psychiatry; 2000; 41(3):223-7. PubMed ID: 10834632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociative disorders and suicidality in psychiatric outpatients.
    Foote B; Smolin Y; Neft DI; Lipschitz D
    J Nerv Ment Dis; 2008 Jan; 196(1):29-36. PubMed ID: 18195639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of psychodynamically oriented trauma-focused inpatient treatment for women with complex posttraumatic stress disorder (PTSD) and borderline personality disorder (BPD).
    Sachsse U; Vogel C; Leichsenring F
    Bull Menninger Clin; 2006; 70(2):125-44. PubMed ID: 16753036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacotherapy of borderline disorders. A review of the literature].
    Dulz B
    Nervenarzt; 1994 Nov; 65(11):755-61. PubMed ID: 7816151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of borderline personality disorder with opioid antagonists: buprenorphine, nalmefene, naloxone and naltrexone in the treatment of dissociative symptoms, self-mutilation and suicidal behavior].
    García MC
    Vertex; 2020 Apr; XXX(148):1-10. PubMed ID: 33890928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of dissociative symptoms in borderline patients with naltrexone].
    Schmahl C; Stiglmayr C; Böhme R; Bohus M
    Nervenarzt; 1999 Mar; 70(3):262-4. PubMed ID: 10231814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychological organization of multiple personality disordered patients as revealed in psychological testing.
    Armstrong J
    Psychiatr Clin North Am; 1991 Sep; 14(3):533-46. PubMed ID: 1946023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone for Self-Injury in Borderline Personality With Venlafaxine-Associated Hyponatremia.
    DeLucia B
    J Clin Psychopharmacol; 2017 Dec; 37(6):743-745. PubMed ID: 28891834
    [No Abstract]   [Full Text] [Related]  

  • 16. [Low dose naltrexone in the treatment of dissociative symptoms].
    Pape W; Wöller W
    Nervenarzt; 2015 Mar; 86(3):346-51. PubMed ID: 25421416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can psychotherapy rescue naltrexone treatment of opioid addiction?
    Rounsaville BJ
    NIDA Res Monogr; 1995; 150():37-52. PubMed ID: 8742771
    [No Abstract]   [Full Text] [Related]  

  • 18. Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder.
    Philipsen A; Richter H; Schmahl C; Peters J; Rüsch N; Bohus M; Lieb K
    J Clin Psychiatry; 2004 Oct; 65(10):1414-9. PubMed ID: 15491247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of dissociative disorders treatment studies.
    Brand BL; Classen CC; McNary SW; Zaveri P
    J Nerv Ment Dis; 2009 Sep; 197(9):646-54. PubMed ID: 19752643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychotherapy-drugs combined. Mixed psychotherapeutic-chemotherapeutic treatment. Countertransference aspects].
    Fraschina B
    Acta Psychiatr Belg; 1984; 84(1):50-64. PubMed ID: 6720331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.